Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Innovative Technology Enables First Crystal Structure of mGlu5 Transmembrane Domain to be Determined
Several novel drug candidates have been identified to help treat specific neuropsychiatric disorders.
Capturing Cancer: A Powerful New Technique for Early Diagnosis
Researchers describe an innovative technique for early disease detection, which they call immunosignaturing.
Significant Step Towards Blood Test for Alzheimer's
Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer’s, marking a significant step towards developing a blood test for the disease.
Potential Alzheimer’s Drug Prevents Abnormal Blood Clots in the Brain
Researchers have identified a compound that might halt the progression of Alzheimer’s by interfering with the role of plaque forming amyloid-ß.
CRI Finds Key to Identifying, Enriching Mesenchymal Stem Cells
Biomarker enables researchers to accurately characterize the properties and function of MSCs in the body.
Finding Could Revolutionize Drug Discovery
A study by researchers at IRB Barcelona reveals the existence of information highways that connect and correlate distant sites within a single protein.
Advanced Cell Culture Techniques for Cancer Drug Discovery
This review focuses on the culturing of cell lines representative of solid cancers in advanced cell culture conditions.
Detailed Brain Imaging Study to Help Unlock Root Causes of Dementia
Large population scanning heralds a new era in research to tackle dementia and a wide range of intractable diseases.
Combining Weak Chemical Forces to Strengthen a Novel Imaging Technology
Illinois researchers turn current contrast agent technology on its head—or rather, they turn it inside out.
Chemists Discover Cancer Drug Candidate Structure
Chemists at The Scripps Research Institute have determined the correct structure of a highly promising anticancer compound approved by the U.S. FDA for clinical trials in cancer patients.
Scroll Up
Scroll Down
Return
A High Quality High Content Screening Assay for Intracellular Leishmania
Manu De Rycker, University of Dundee, speaking at Screening Europe 2011
Date Posted: Saturday, February 18, 2012
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Dundee Researchers Seek to Beat "Molecular Obesity"
Researchers from the University of Dundee have come up with a new innovative approach in the quest to reduce failure rates in the drug discovery process.
Thursday, January 26, 2012
Visualising the Problem may help to Improve Antibiotics
Researchers from the Universities of Dundee and Oxford have made a significant breakthrough in understanding how resistance to antibiotics might be overcome, by producing the first ever 3D molecular image of a key drug target and showing how drugs bind to it.
Monday, January 17, 2011
University of Dundee First to Install Biacore 4000 SPR System
The system will be used to focus on developing biophysical fragment based screening methodologies for efficient drug discovery.
Wednesday, June 16, 2010
New Programme Leader Appointed to Dundee MRC Unit
MRC Protein Phosphorylation Unit recruits Dr Ian Ganley from the Memorial Sloan Kettering Cancer Center.
Tuesday, March 02, 2010
Dundee Centre to Focus on Cancer Prevention and Screening
Cancer experts from across a wide range of disciplines at the University of Dundee are to pool their efforts to push forward research into developing effective programmes of prevention and early screening for the disease.
Monday, October 26, 2009
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv